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Introduction {#sec1}
============

Although the brain accounts for only 2% of the total body mass, it is one of the most energy-consuming organs, requiring up to 20% of the oxygen and 25% of the glucose metabolized by the body. These substrates are converted to ATP through glycolysis and oxidative phosphorylation, the latter taking place in mitochondria. Hence, around 20% of the ATP produced in the body is devoted to the brain. Importantly, brain functions depend on an adequate energy supply. Indeed, reducing the brain supply of glucose or oxygen even for short periods leads to severe brain damage, as observed following ischemic stroke. Numerous reports support a role for glucose as a potent modulator of learning and memory, including behavioral tasks, in both humans and rodents. Indeed, both peripheral and direct central glucose administration enhances cognitive processes ([@bib12]). Similarly, astrocytes-derived lactate, the end product of glycolysis, was reported to be necessary for the formation of long-term memory ([@bib34]). Consistent with these observations, brain imaging approaches are based on the detection of signals that are directly related to energy supply and use. For instance, positron emission tomography (PET) reveals changes in cerebral blood flow, glucose uptake, and oxygen consumption according to the tracer that is used. These imaging approaches have been instrumental in demonstrating that brain activity is coupled to increased energy availability and consumption. Further studies have demonstrated that 85% of the energy required by the brain is used by neurons and is devoted to glutamatergic transmission ([@bib2], [@bib14]).

Failure to maintain proper energy levels in the brain also leads to neurodegeneration. The main neurodegenerative diseases are characterized by dysregulations of energy metabolism ([@bib11]). For instance, Alzheimer disease (AD) is characterized by mitochondrial dysfunctions ([@bib26]) and early glucose hypometabolism ([@bib31]). Of note, \[^18^F\] fluorodeoxyglucose (FDG)-PET, a marker for glucose utilization, was recently described as being the most accurate biomarker for AD. Indeed, FDG-PET allowed to correctly differentiate subjects who progressed to AD or other dementia from those who remained stable or reverted to normal cognition ([@bib6]). Finally, although these metabolic impairments were proposed to play a causative role in disease pathogenesis, their causes and consequences remain to be established.

One of the most important cell energy sensors and regulators is the AMP-activated protein kinase (AMPK). AMPK is a serine/threonine protein kinase composed of three subunits. It possesses one catalytic subunit alpha and two regulatory subunits beta and gamma. The gamma subunit holds adenine-nucleotide-binding sites that allow the sensing of intracellular levels of AMP, ADP, and ATP. Consequently, any energetic stress that will modify the intracellular AMP/ATP ratio will enhance the activation of AMPK ([@bib39]). The activation of AMPK requires its phosphorylation on threonine 172 within its catalytic alpha subunit. Two main kinases were reported to fulfill this role, the liver kinase B1, which is thought to be constitutively activated and involved in AMPK phosphorylation in energy stress conditions ([@bib16], [@bib38]), and the Ca^2+^/calmodulin-dependent protein kinase kinase-beta (CaMKKβ), whose activation is dependent on intracellular calcium levels ([@bib17]). AMPK is highly expressed in the brain, and in particular, in neurons. Interestingly, several studies have reported an over-activation of neuronal AMPK in the brain of patients with AD ([@bib35]), Parkinson disease ([@bib23]), and Huntington disease ([@bib24]), thus supporting the defective metabolism hypothesis in these disorders ([@bib9]).

Although it is obvious that brain energy metabolism must be tightly regulated to sustain neuronal function and cognition, the molecular mechanisms involved in this regulation remain poorly understood. In particular, how neurons meet their energy demand to sustain synaptic transmission remains to be established. In this study, we assessed the possibility that AMPK might play a critical role in the regulation of energy metabolism in neurons in response to their activation.

Results {#sec2}
=======

AMPK Is Stimulated following Synaptic Activation {#sec2.1}
------------------------------------------------

To assess the molecular pathways involved in neuronal energy level maintenance, we used bicuculline and 4-aminopyridine (Bic/4-AP) to induce synaptic release of glutamate in differentiated primary neurons. This well-established protocol ([@bib13], [@bib19]) is known to preferentially induce glutamatergic neurotransmission that we will refer to hereafter as synaptic activation (SA). To validate the efficiency of this protocol in our model, we first assessed the activation status of a signaling pathway known to be activated following SA, the MAPK pathway. SA induction in 15 days *in vitro* differentiated mouse primary neurons led to a rapid phosphorylation of the main MAPK pathway components, ERK, RSK, MSK, and MEK, which are representative of this signaling pathway activation ([Figure S1](#mmc1){ref-type="supplementary-material"}A). In addition, blockade of glutamatergic N-methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the specific inhibitors MK-801 and NBQX, respectively, completely abolished the activation of ERK, confirming that MAPK activation is dependent on the stimulation of glutamate receptors ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Together, these results confirm the validity of the SA protocol in our model. To allow a more general screening of the signaling pathways activated following SA we used a kinase array approach. After 5 min Bic/4-AP stimulation, we detected an increase in the phosphorylation status of ERK, MSK, and CREB, as expected from our previous data ([Figures 1](#fig1){ref-type="fig"}A, 1B, and 1E). Interestingly, an increase in the phosphorylation levels of AMPK was also observed following Bic/4-AP treatment. AMPK activation was further assessed by western blot using phospho-specific antibodies directed against the AMPK-Thr^172^ epitope, which is a prerequisite for AMPK activity, and acetyl-CoA carboxylase (ACC)-Ser^79^, a direct AMPK target ([Figures 1](#fig1){ref-type="fig"}G--1I). Following SA, we observed a rapid phosphorylation of AMPK and ACC, thus demonstrating that the AMPK signaling pathway was activated ([Figures 1](#fig1){ref-type="fig"}G--1I). This activation was also dependent on glutamate receptor activation since their inhibition significantly reduced AMPK activation ([Figures S1](#mmc1){ref-type="supplementary-material"}B--S1D). Given that SA leads to intracellular calcium influx and that AMPK was reported to be phosphorylated by the calcium-dependent protein kinase CaMKKβ in neuronal cells, we used the CaMKKβ-specific inhibitor STO-609 to address this possibility. However, our results showed that in our model CaMKKβ was not responsible for the SA-induced AMPK activation ([Figure S2](#mmc1){ref-type="supplementary-material"}), thus strongly suggesting that AMPK phosphorylation was not related to intracellular calcium levels. Since SA is a very energetic process, it is likely that AMPK activation might be related to changes in ATP levels. To assess the importance of energy level maintenance for the signaling pathways induced by SA, primary neurons were pre-treated with a combination of oligomycin, an ATP synthase inhibitor, and 2-deoxy-D-glucose, a glycolysis inhibitor (Oligo/2-DG) to deplete intracellular ATP ([Figure 1](#fig1){ref-type="fig"}F). In these conditions of energy depletion, SA failed to activate the MAPK signaling pathway ([Figures 1](#fig1){ref-type="fig"}C--1E). However, AMPK activity was increased in both conditions ([Figures 1](#fig1){ref-type="fig"}C--1E). Altogether, our data show that the activation of the MAPK signaling pathway by SA is contingent upon intracellular energy levels, suggesting a role of AMPK in their regulation.Figure 1AMPK Is Activated upon Synaptic Activation(A--D) 15 days *in vitro* (DIV) differentiated primary neurons were stimulated with Bic/4-AP (5 min) in the presence or absence of oligomycin and 2-deoxy-D-glucose (Oligo/2-DG, 5-min pre-treatment 1 μM/50 mM). Cell extracts were then probed on phosphoprotein arrays ((A)--(D), upper boxes show phosphorylated ERK1/2 \[Thr^202^/Tyr^204^, Thr^185^/Tyr^187^\] and lower boxes show phosphorylated AMPK \[Thr^172^\]).(E) Quantification of the kinase array represented as a heatmap; results are expressed as percentage of the control (Ctrl).(F) Intracellular ATP quantifications following 5-min Oligo/2-DG treatment (n = 3).(G) Western blot (WB) analysis of phosphorylated ACC and AMPK and total ACC, AMPK, and actin in lysates obtained from 15 DIV neurons stimulated with Bic/4-AP for the indicated times. WB is representative of at least 4 independent experiments.(H and I) WB quantifications showing the ratios of phosphorylated AMPK/total AMPK (pAMPK/AMPK) (H) and phosphorylated ACC/total ACC (pACC/ACC) (I) following Bic/4-AP stimulation (n = 4).Results show means ± SD. Student\'s t test (F) and one-way ANOVA with Bonferonni post-hoc test (H--I) were used for evaluation of statistical significance. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

AMPK Activation Is Necessary to Induce Neuronal Metabolic Plasticity in Response to Synaptic Activation {#sec2.2}
-------------------------------------------------------------------------------------------------------

To test whether AMPK was involved in the maintenance of energy levels during SA, we assessed metabolic fluxes in differentiated live neurons using the extracellular flux analyzer Seahorse XFe24 ([@bib29]). Glycolytic flux was determined by measuring the extracellular acidification rate (ECAR) due to H^+^ release in combination with lactate, and mitochondrial respiration was determined by measuring the oxygen consumption rate (OCR). Following Bic/4-AP stimulation, ECAR and OCR were increased, showing that both glycolysis and mitochondrial respiration were enhanced to maintain energy levels following SA ([Figures 2](#fig2){ref-type="fig"}A and 2G, green arrows, and [Figures 2](#fig2){ref-type="fig"}C and 2I). Several metabolic parameters were determined using calculations described in the [Methods](#sec4){ref-type="sec"} section. Interestingly, Bic/4-AP stimulation did not change the overall glycolytic reserve ([Figure 2](#fig2){ref-type="fig"}E), maximal respiration ([Figure 2](#fig2){ref-type="fig"}K), or spare respiratory capacity ([Figure 2](#fig2){ref-type="fig"}L). However, in the presence of Bic/4-AP stimulation, the cells engage a larger fraction of the existing glycolytic reserve ([Figure 2](#fig2){ref-type="fig"}F) and spare respiratory capacity ([Figure 2](#fig2){ref-type="fig"}M) to increase energy production ([Figure 2](#fig2){ref-type="fig"}J). To determine the involvement of AMPK in this metabolic up-regulation induced following SA, neurons were pre-treated with the AMPK inhibitor compound C (Cc). Our results showed that AMPK inhibition prohibited the up-regulation of glycolysis and mitochondrial respiration that were induced by SA ([Figures 2](#fig2){ref-type="fig"}A--2M). Although AMPK inhibition in basal conditions (without SA induction) did not affect overall basal glycolysis or mitochondrial functions ([Figure S3](#mmc1){ref-type="supplementary-material"}), it significantly reduced the use of the spare glycolytic reserve and spare respiratory capacity induced by SA ([Figures 2](#fig2){ref-type="fig"}F and 2M). Similar results were obtained using a kinase-dead dominant-negative construct of AMPK therefore excluding any potential off-target effect of Cc ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Finally, the phenogram analysis, which defines the overall cellular metabolic state of the cells, demonstrated that SA induced by Bic/4-AP led to a shift toward a metabolic state of the neurons ([Figure 2](#fig2){ref-type="fig"}N) that we will refer to as their metabolic plasticity. AMPK inhibition using Cc almost completely abolished this shift ([Figure 2](#fig2){ref-type="fig"}N), thereby suggesting that AMPK activity is necessary to maintain energy levels during SA. To confirm this, intracellular ATP levels were quantified in neurons at different time points following SA in the presence or absence of Cc. In control and SA conditions ATP levels remained constant, whereas AMPK repression led to a significant rapid drop in ATP levels in conditions of SA ([Figure 2](#fig2){ref-type="fig"}O). These results showed that AMPK activity following SA is essential to maintain neuronal energy levels.Figure 2AMPK Maintains Energy Levels by Up-regulating Glycolysis and Mitochondrial Respiration during Synaptic Activity(A--M) Extracellular acidification rate (ECAR, A) and oxygen consumption rate (OCR, G) measured using the Seahorse XFe24 technology after Bic/4-AP stimulation (green arrows) in the presence or absence of the AMPK inhibitor compound C (Cc, 10 μM). (A) ECAR profile is monitored under basal conditions and upon the sequential injection of saturating concentration of glucose, followed by Bic/4-AP, or assay medium in control (Ctrl) group, oligomycin (Oligo), and 2-deoxy-D-glucose (2-DG) as indicated by arrows. (G) OCR profile monitored under basal condition and following the sequential injection of assay medium, in Ctrl group, or Bic/4-AP, in the stimulated groups, Oligo, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), and rotenone and antimycin A (Rot/AA) as indicated by arrows. ECAR and OCR are indicators of glycolysis and mitochondrial respiration, respectively. (B) Basal glycolysis, (C) glycolytic response to treatment, (D) glycolytic capacity, (E) spare glycolytic reserve expressed as mpH/min, (F) spare glycolytic reserve after treatment expressed as percentage of baseline, (H) basal respiration, (I) oxphos response to treatment, (J) ATP turnover coupled to treatment, (K) maximal respiration, (L) spare respiratory capacity expressed as pM O~2~/min, and (M) spare respiratory capacity after treatment expressed as percentage of baseline were calculated as described in the [Methods](#sec4){ref-type="sec"} section; n = 4--5.(N) Phenogram obtained by plotting the values obtained from the study of glycolysis (A) and mitochondrial respiration (G) following Bic/4-AP stimulation.(O) Intracellular ATP levels in neurons stimulated with Bic/4-AP for the indicated times in the presence or absence of Cc (n = 3--4). Values are expressed as percentage of ATP in the Ctrl at time 0.Results show mean ± SD. One-way ANOVA (B--F and H--M) and two-way ANOVA (O) followed by Bonferroni\'s post-hoc test were used for the evaluation of statistical significance. \*p \< 0.05, \*\*p \< 0.01, \*\*\*p \< 0.001. See also [Figures S3--S5](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

AMPK Up-regulates Mitochondrial Respiration in Response to Synaptic Activation {#sec2.3}
------------------------------------------------------------------------------

Glycolysis and mitochondrial respiration are tightly coupled together. Given that neurons are mainly oxidative cells, we asked whether the increase in mitochondrial respiration induced by SA was dependent on glycolysis up-regulation or whether AMPK could have a more direct impact on mitochondria. To assess the latter, we investigated its involvement in the oxidation of mitochondrial substrates that do not require prior glycolysis. As neurons were reported to use lactate as an alternative substrate to glucose in the context of the astrocyte-neuron lactate shuttle, we substituted glucose with lactate in the Seahorse XFe24 experiments. In these conditions, SA up-regulated mitochondrial respiration ([Figures S5](#mmc1){ref-type="supplementary-material"}A--S5F), as it was previously observed with glucose. This metabolic response to SA was inhibited by the presence of Cc, showing that AMPK is also involved in the regulation of lactate utilization following SA. Importantly, these results support a more direct role of AMPK in mitochondrial function. Given that neurons were also reported to use glutamine for energy ([@bib8]), we repeated these experiments with a media devoid of glucose. Results showed that following SA, neurons did not use the glutamine present in the culture media to increase their energy production ([Figures S5](#mmc1){ref-type="supplementary-material"}G--S5L). To go further, we performed metabolomics to determine the fluxes throughout the central carbon metabolism using ^13^C stable-isotope tracing. For this, neurons were cultured in the presence of uniformly ^13^C-labeled glucose, and fractional contribution was quantified using mass spectrometry (isotopologs were designated as m0, m1, m2, m3, ...). An increase in labeled lactate confirmed the increased glycolytic flow under SA conditions that was prohibited by Cc ([Figure 3](#fig3){ref-type="fig"}A). Furthermore, analysis of the isotopolog profiles of the tricarboxylic acid cycle (TCA) metabolites demonstrated significant changes ([Figures 3](#fig3){ref-type="fig"}B--3H). Of particular interest is the significant increase in the levels of m3 isotopomers in SA from citrate, succinate, fumarate, and malate, suggesting that SA induced a shift toward pyruvate carboxylation ([@bib5]). Higher abundances of m4, m5, and m6 isotopologs from citrate were observed following Bic/4-AP stimulation ([Figure 3](#fig3){ref-type="fig"}C). These isotopomers require the combined action of pyruvate dehydrogenase (PDH), pyruvate carboxylase (PC), and multiple turns of the Kerbs cycle, as explained in [Figure 3](#fig3){ref-type="fig"}B. These results suggest that Bic/4-AP stimulation induced a shift toward anaplerotic pyruvate carboxylation that was not observed when AMPK activity was repressed. Altogether, these data support the notion that AMPK activity is needed to induce the metabolic "reprogramming" that occurs following SA.Figure 3AMPK Up-regulates Mitochondrial Metabolism upon Synaptic ActivationMeasurement of ^13^C-glucose-derived metabolites, calculated as percentage of the total metabolite pool following liquid chromatography-mass spectrometry analysis of primary neurons after 30 min in culture with ^13^C-glucose-supplemented media with or without Bic/4-AP stimulation.(A) Metabolic profile of glycolysis intermediates.(B) Schematic representation of the labeling patterns of metabolic intermediates starting from uniformly labeled glucose. The letter "m" indicates the number of carbon atoms labeled with ^13^C. The blue filled circles represent ^13^C atoms derived from pyruvate dehydrogenase activity, whereas the dashed circles represent ^13^C atoms derived from the pyruvate carboxylase activity.(C--H) Isotopolog quantification of the Krebs cycle intermediates citrate (C), isocitrate (D), α-ketoglutarate (E), succinate (F), fumarate (G), and malate (H). Metabolic profiles are expressed as heatmaps. n = 3.See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Neuronal Metabolic Plasticity Induced by AMPK Is Crucial for Immediate-Early Genes Expression, Synaptic Plasticity, and Long-Term Memory Formation {#sec2.4}
--------------------------------------------------------------------------------------------------------------------------------------------------

We next sought to determine the importance of this metabolic plasticity regulated by AMPK for neuronal functions. SA, when sustained, leads to the expression of immediate-early genes (IEGs) that include Arc, cFos, and Egrl. These genes are known to modulate the neuronal plasticity underlying learning and memory. In our model of SA, we observed the expression of these IEGs starting 1 hr after Bic/4-AP treatment ([Figure 4](#fig4){ref-type="fig"}A). This induction of IEG expression was inhibited when the energetic status was disrupted by either the inhibition of glycolysis with the glyceraldehyde-3-phosphate dehydrogenase inhibitor iodoacetate or 2-DG or the interruption of mitochondrial respiration using oligomycin and the inhibitors of complexes I and III rotenone and antimycin A, respectively ([Figure 4](#fig4){ref-type="fig"}B). These results demonstrated that the maintenance of energy levels is crucial for the expression of IEGs. In addition, AMPK inhibition also led to a significant reduction of IEG expression following SA ([Figures 4](#fig4){ref-type="fig"}C and [S4](#mmc1){ref-type="supplementary-material"}C), showing that AMPK-mediated metabolic plasticity is necessary for the expression of IEGs following SA.Figure 4AMPK Activation Following Synaptic Activity Is Necessary for IEG Expression, Synaptic Plasticity, and Long-Term Memory Formation(A) Western blot (WB) analysis of the IEGs Arc, EgrI, and cFos expression following Bic/4-AP stimulation for the indicated times in differentiated primary neurons at 15 DIV (days *in vitro*). WB is representative of at least 5 independent experiments.(B) WB analysis of the IEGs Arc, EgrI, and cFos expression following 2 hr Bic/4-AP stimulation in the presence or absence of glycolysis inhibitors (2-DG 50 mM, Iodo 100 μM pre-treatment of 5 min) or mitochondrial respiration inhibitors (Oligo 1 μM, rotenone \[Rot\] 1 μM, antimycin A \[AA\] 1 μM pre-treatment of 5 min) in differentiated primary neurons at 15 DIV. WB is representative of at least 4 independent experiments.(C) WB analysis of the IEGs Arc, EgrI, and cFos expression following 2 hr Bic/4-AP stimulation in the presence or absence of Cc (20 min pre-treatment, 10 μM). WB is representative of at least 4 independent experiments.(D) Recording of LTP in the CA1 region of the hippocampus *ex vivo*. Triple application of an electrical theta burst stimulation protocol induced robust LTP in controls. However, in slices treated with 10 μM Cc, the same stimulation generated only an impaired, decremental potentiation, returning to baseline values after about 80 min (Wilcoxon test). This resulted in a highly significant difference (F~1,13~ = 120.105; p \< 0.001, RM-ANOVA). Data are presented as mean ± SEM, where n refers to the number of animals tested.(E) Schematic representation of the IA protocol timeline.(F) Hippocampal injections of Cc 20 min before the IA training (Acq) disrupted long-term memory at 24 hr (Test 1). The disruption persisted 6 days after training (Test 2). Cc-injected mice had normal retention after retraining (Test 3). n = 10, results show mean ± SEM.One-way ANOVA followed by Bonferroni\'s post-hoc test was used for evaluation of statistical significance. \*\*\*p \< 0.001. See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

To examine the impact of AMPK inhibition on synaptic plasticity under more physiological conditions, we took advantage of *ex vivo* hippocampal slices. Thus, we investigated a putative role of AMPK in long-term potentiation (LTP) in the CA1 region of the hippocampus, a well-established model of learning and memory at the cellular level. As depicted in [Figure 4](#fig4){ref-type="fig"}D, triple application of an electrical theta burst stimulation protocol resulted in robust LTP in control (vehicle) with initial values of 213.3 ± 5.3% (n = 7), which were retained at about this level until 4 hr after induction (197.5 ± 15.1%). This robust type of LTP is protein synthesis dependent and therefore a relevant model for the formation of long-term memory (Ahmed and Balschun, unpublished data). Application of 10 μM Cc, in contrast, caused a severe impairment of LTP with a significantly lower initial magnitude of 146.2 ± 9.4% (p = 0.0001 Welch test) and a decremental potentiation that returned to baseline values after about 80 min (Wilcoxon test). Overall, this resulted in a highly significant difference in LTP in control mice (F~1,13~ = 120.105; p \< 0.001, repeated measures (RM)-ANOVA) underlining an essential function of AMPK in long-term synaptic plasticity. Furthermore, quantification of the LTP defect, in percentage, of control for the average of first 30 min used as a measure of induction (vehicle LTP: 200% ± 7%, n = 11; Cc LTP: 126% ± 6%, n = 8; RM-ANOVA \[F~1,17~\] = 25.58, p \< 0.0001) and for the average of 210--240 min used as a measure of late maintenance (vehicle LTP: 159% ± 9%, n = 11; Cc LTP: 77% ± 11%, n = 8; RM-ANOVA \[F~1,17~\] = 25.58 p \< 0.0001) demonstrated that Cc reduced both the induction and the late maintenance phases.

Finally, to evaluate the importance of AMPK-mediated metabolic plasticity *in vivo*, we tested whether AMPK activation is involved in long-term memory retention. To this end, Cc was bilaterally injected in the hippocampus of awake wild-type mice 20 min before inhibitory avoidance (IA) training, a task that depends on the proper functioning of the hippocampus ([@bib22], [@bib37]) ([Figures 4](#fig4){ref-type="fig"}E and 4F). Cc injection did not affect IA acquisition, as the mean latencies to enter the shock compartment during training (Acq) were similar in both groups. However, Cc significantly blocked long-term memory tested at 24 hr (Test 1). Retesting 6 days after acquisition (Test 2) showed that the memory loss persisted. Retraining of the Cc injected group resulted in normal memory retention 24 hr later (Test 3), indicating that the hippocampus was functionally intact. Altogether, these results show that AMPK is involved in long-term memory formation and provided proof of concept that AMPK plays an essential role in cognitive processes.

AMPK Deregulation Impairs the Neuronal Metabolic Plasticity Induced by Synaptic Activation {#sec2.5}
------------------------------------------------------------------------------------------

Last, we asked whether AMPK deregulation as it is observed in AD could impair AMPK-mediated metabolic plasticity induced by SA. Since AMPK is over-activated in neurons of patients with AD when compared with control patients ([@bib35]), we mimicked this condition by treating primary neurons with AICAR, an AMPK agonist, 24 hr before inducing SA (referred to as pre-activation hereafter). AMPK pre-activation with AICAR did not modify the metabolic profile of neurons, whereas it greatly impaired the ability of neurons to up-regulate mitochondrial respiration in response to SA ([Figures 5](#fig5){ref-type="fig"}A and 5B). Similar results were obtained after over-expression of a constitutively active mutant of AMPK (CA-AMPK) in neurons ([Figure 5](#fig5){ref-type="fig"}C), further supporting the inhibitory effect of AMPK pre-activation on the metabolic response to SA. We then assessed the effect of AMPK pre-activation on neuronal ATP content during SA ([Figure S6](#mmc1){ref-type="supplementary-material"}). Our results showed that, when compared with unstimulated cells, ATP content, both in control and AICAR pre-treated groups remained constant during SA. These results suggest that AMPK pre-activation might have produced metabolic alterations that prevented SA from occurring in a different way than the acute inhibition observed with Cc. In this context, the pre-activation of AMPK either using AICAR or CA-AMPK also prevented the SA-induced expression of IEGs ([Figures 5](#fig5){ref-type="fig"}D and 5E). Altogether, our results show that a tight regulation of AMPK is important for the physiological metabolic response of neurons to SA and for the triggering of processes leading to neuronal plasticity.Figure 5AMPK Pre-activation Prevents Neuronal Metabolic Response to SA(A) Mitochondrial respiration profile in primary neurons evaluated using the Seahorse XFe24 technology to investigate the impact of long-lasting (24 hr) AMPK activation induced by AICAR in response to Bic/4-AP. Mitochondrial respiration profile, expressed as oxygen consumption rate (OCR), is monitored upon the injection of assay medium, in control group (Ctrl) and in cells treated with AICAR (AICAR), or upon the injection of Bic/4-AP in the absence (Bic/4-AP) or presence of AICAR (Bic/4-AP + AICAR), followed by injection of Oligo, carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), and rotenone and antimycin A \[Rot/AA\] as indicated by the arrows. Results are representative of 3 independent experiments.(B) OCR response to Bic/4-AP stimulation expressed as pMO~2~/min (n = 3).(C) OCR response to Bic/4-AP stimulation expressed as pMO~2~/min in primary neurons over-expressing a constitutively active (CA) form of AMPK (n = 3).(D) Immunoblotting with phosphorylated ACC (pACC), phosphorylated AMPK (pAMPK), Arc, EgrI, cFos, and actin in lysates obtained from 15 days *in vitro* (DIV) neurons stimulated with Bic/4-AP for 2 hr after pre-treatment with AICAR (24 hr, 1 mM). Results are representative of at least 5 independent experiments. Quantification of western blot (WB) showing the expression of the IEGs Arc, EgrI, and cFos (n = 5).(E) Immunoblotting with total AMPK (\# CA labels the over-expressed CA-AMPK construct), Arc, EgrI, cFos, and actin in lysates obtained from 15 DIV neurons stimulated with Bic/4-AP for 2 hr, 4 days after injection with CA-AMPK. Results are representative of at least 3 experiments. Quantification of WB showing the expression of the IEGs Arc, EgrI, and cFos (n = 3).Results show mean ± SD. One-way ANOVA followed by Bonferroni\'s post-hoc test was used for evaluation of statistical significance. \*p \< 0.05, \*\*\*p \< 0.001. See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

Neurons have high energy demands that are met through the oxidation of glucose via glycolysis and mitochondrial respiration. Neuronal activity is a process known to require and thus stimulate ATP production ([@bib33]); however, the molecular mechanisms involved in this regulation remain poorly understood. Here, we demonstrated that the AMPK-mediated signaling pathway plays a key role in this regulation. We found that AMPK is rapidly activated following SA to maintain energy levels via the up-regulation of glycolytic and mitochondrial use of glucose. Regulation of glucose uptake by AMPK in neurons has been previously described. AMPK was proposed to regulate glucose transporters GLUT3 and GLUT4 surface expression following glutamate excitation and action potential firing, respectively ([@bib1], [@bib36]). It is possible that a mobilization of glucose transporters to the plasma membrane also occurs in our conditions, which could explain how AMPK regulates glycolysis. Our results, in addition to validate the increased glycolysis following SA, also demonstrate that mitochondrial respiration plays an important part in sustaining energy levels. Indeed, our data demonstrate that AMPK also acts on mitochondrial respiration independent of glycolysis. Actually, consistent with their high energy requirements, neurons sustain a high rate of oxidative metabolism ([@bib4]). Bearing this in mind, the importance of mitochondria for cognitive functions has recently regained importance. In particular, a recent study has shown that cannabinoid receptors present on mitochondria (mtCB1) are responsible for amnesia induced by acute cannabinoid intoxication. In particular, activation of hippocampal mtCB1 receptors led to memory impairments due to decreased mitochondrial respiration ([@bib18]). Our study reinforces this link between mitochondrial activity and memory formation. Our results also raised the question of AMPK subcellular localization. Indeed, it could be speculated that a pool of AMPK might be present at or within the mitochondria to up-regulate mitochondrial respiration. Previous reports have also highlighted this possibility ([@bib25]). In our context, further work will be required to determine whether PC or PDH could be direct AMPK substrates. In particular, PC catalyzes the conversion of pyruvate to oxaloacetate, named pyruvate carboxylation, within the mitochondria. Although this step, which leads to *de novo* synthesis of TCA cycle intermediates is crucial to replenish TCA cycle and supports the formation of transmitter glutamate, is widely described to occur in astrocytes, PC activity was also reported in neurons (for review see \[[@bib15]\]). Another way to replenish TCA is via glutaminolysis. Although this possibility cannot be excluded, it seems not to be involved in our model given that the experiments performed without glucose did not show any response to SA, although glutamine was present in cell culture media. Another interesting possibility is the regulation by AMPK of the AKAP1 (A kinase anchor protein 1) protein, which was identified in muscle by a global phosphoproteomic approach ([@bib20]). This direct phosphorylation of AKAP1 by AMPK was reported to regulate mitochondrial respiration ([@bib20]). Although we assessed only the immediate metabolic response of neurons to synaptic activity, it will also be interesting to determine whether AMPK could be involved in gene expression changes that promote the neuronal Warburg effect in response to prolonged Bic/4-AP stimulation ([@bib3]).

Our results are also particularly important in the context of neurodegenerative disorders in which energy metabolism is strongly impaired and AMPK is over-activated ([@bib23], [@bib24], [@bib35]). In conditions of over-activation, AMPK is unlikely to respond properly to SA, perhaps as a way to preserve energy levels. As a consequence, we propose that AMPK might act as a metabolic switch that determines whether SA may or may not occur according to the currently available energy levels (and hence metabolic substrate) in its vicinity. It is also possible that AMPK over-activation could indirectly impair the metabolic plasticity response to SA. Under these conditions, the identification of AMPK targets as well as the consequences of AMPK over-activation on synaptic integrity will be of interest. Supporting this hypothesis, previous reports have determined that AMPK activation by pharmacological drugs led to impairments in synaptic plasticity ([@bib32]) and memory formation ([@bib7]). In addition, in the context of AD, AMPK was proposed to be a key player in the reduction of number of dendritic spine ([@bib28]) and in the LTP impairments induced by Aβ oligomers ([@bib27]). These reports show that up-regulation of AMPK activity has the same negative outcome on synaptic plasticity and memory formation as AMPK inhibition.

Altogether, our data suggest that AMPK activity has to be fine-tuned extremely well since any hypo- or hyperactivation will have detrimental consequences on synaptic plasticity and hence memory formation.

In summary, our results demonstrate that AMPK plays a critical role during glutamatergic SA. In particular, we show that AMPK activity is crucial to maintain neuronal energy levels and hence is involved in memory formation processes. Our study establishes AMPK as an important link between memory formation and energy metabolism and suggests that it could act as a metabolic checkpoint by sensing the availability of energy substrates. These findings might also be of value in the context of diabetes and obesity, conditions that are associated with cognitive ([@bib10], [@bib30]) and central metabolism ([@bib21]) impairments in humans.

Limitations of Study {#sec3.1}
--------------------

Our data also demonstrate that the energetic metabolic up-regulation mediated by AMPK is crucial for the expression of IEGs, synaptic plasticity, and long-term memory formation. In line with these results, AMPK was reported to be activated and necessary for LTP induced *in vivo* by high-frequency stimulation ([@bib40]). However, our *in vivo* data were obtained using a pharmacological approach to inhibit AMPK; therefore for a more thorough understanding of these processes, the generation of conditional AMPK knockout mouse models will be necessary to disentangle the importance of neuronal AMPK in particular types and phases of memory.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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Document S1. Transparent Methods and Figures S1--S7
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